IP Verse

Frese competitive analysis

Latest oppositions filed by Frese

Explore patent oppositions filed by Frese against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition Date
EP4307923
Liquid Nutritional Composition Suitable For Muscle FunctionNUTRICIAMar 24, 2026
EP3996527
Food Compositions For Weight ManagementNESTLEMar 23, 2026
EP4135527
Process For The Manufacturing Of Fermented Dairy Product SubstitutesTECHNION RESEARCH & FOUNDATIONMar 2, 2026
EP4103247
Solution Verification Prior To Therapy In Renal Insufficiency TreatmentGAMBRO LUNDIAFeb 27, 2026
EP3389393
Heat Sterilized High Protein Compositions Comprising Whey Protein And At Least One Component Selected From (I) A Saccharide, (Ii) A Phosphate And (Iii) A CitrateNESTECFeb 6, 2026
EP3709812
Wheat Based Binding AgentMANILDRA MILLINGJan 9, 2026
EP4208216
Automatic Priming And Rinsing Of An Extracorporeal Blood Treatment ApparatusB BRAUN AVITUMJan 7, 2026
EP3329965
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025
EP3773013
Insulin Control In Overweight Or Obese Adult During Life Time InterventionNUTRICIADec 12, 2025
EP3842084
Apparatus For Extracorporeal Blood TreatmentGAMBRO LUNDIANov 12, 2025

Latest patents of Frese opposed by its competitors

Explore Frese's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4076384
Oct 22, 2025Method For Producing Oil-In-Water Emulsions1
EP2854768
Jun 18, 2025Pharmaceutical Compositions Of Pemetrexed3
EP3383202
Apr 2, 2025High Protein Enteral Tube Feed For Icu Patients2
EP3914315
Dec 25, 2024Device For An Extracorporeal Blood Treatment1
EP3411016
Sep 11, 2024High Caloric, High Protein Nutritional Formula2
EP3525781
Apr 24, 2024Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents1
EP3218044
Apr 3, 2024Needleless, Intermittent, Neutral Displacement Iv Injection Port1
EP3131518
Feb 7, 2024Multichamber Bag Opening Aid1
EP3641873
Jan 10, 2024Needleless Iv Injection Port1
EP3411057
Dec 20, 2023High Caloric, High Protein Nutritional Formula Comprising Collagen1

Latest PTAB cases involving Frese

Discover the latest PTAB cases involving Frese, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 17, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Frese

IPR2025-01268Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSDiscretionary Denial
IPR2025-01269Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSInstitution Denied
IPR2022-01065Jun 7, 2022FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHATerminated-Settled
IPR2022-01065Jun 7, 2022FRESENIUS KABI USAZHANGTerminated-Settled
IPR2022-00657Mar 3, 2022FRESENIUS KABI USANOVO NORDISKTerminated-Settled
IPR2022-00657Mar 3, 2022FRESENIUS KABI USAPEDERSENTerminated-Settled
IPR2022-00201Nov 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2022-00201Nov 24, 2021FRESENIUS KABI USAZHANGTerminated-Settled
IPR2021-01542Sep 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01542Sep 24, 2021FRESENIUS KABI USAZHANGTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Frese with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
FRESENIUS KABI DEUTSCHLAND12921 - -
NESTEC46198 - -
NESTLE194257 - -
NUTRICIA171210 - -